InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Roivant Sciences Ltd.

ROIV Clue Score19
Bermuda Fiscal year ends March CIK 0001635088 Results filed 6 Aug 2026
Add to watchlist

What the insiders did Net selling

Individual transactions

46
Insider
Date
Role
Action
Shares
Price
Amount
Melissa B, Epperly
1 Oct 2026
Director
Sold after exercise
900
$36.57
$32.91K
Melissa B, Epperly
1 Oct 2026
Director
Sold after exercise
16,850
$36.08
$607.95K
Eric Venker
30 Sep 2026
President & Immunovant CEO
Sold after exercise
200,000
$36.62
$7.32M
Meghan Fitzgerald
8 Sep 2026
Director
Sold after exercise
20,000
$39.90
$798.00K
Eric Venker
28 Aug 2026
President & Immunovant CEO
Sold after exercise
33,818
$36.44
$1.23M
Eric Venker
28 Aug 2026
President & Immunovant CEO
Sold after exercise
166,182
$35.63
$5.92M
Mayukh Sukhatme
21 Aug 2026
President & CIO
Sold after exercise
144,756
$36.48
$5.28M
Mayukh Sukhatme
20 Aug 2026
President & CIO
Sold after exercise
17,519
$37.30
$653.46K
Mayukh Sukhatme
19 Aug 2026
President & CIO
Sold after exercise
172,899
$37.17
$6.43M
Mayukh Sukhatme
18 Aug 2026
President & CIO
Sold after exercise
31,801
$37.18
$1.18M
Mayukh Sukhatme
18 Aug 2026
President & CIO
Sold after exercise
105,141
$36.59
$3.85M
Mayukh Sukhatme
17 Aug 2026
President & CIO
Sold after exercise
284,707
$36.25
$10.32M
Mayukh Sukhatme
14 Aug 2026
President & CIO
Sold after exercise
243,177
$36.23
$8.81M
Eric Venker
27 Jul 2026
President & Immunovant CEO
Sold after exercise
200,000
$34.95
$6.99M
Meghan Fitzgerald
30 Jun 2026
Director
Sold after exercise
10,000
$34.90
$349.00K
Melissa B, Epperly
29 Jun 2026
Director
Sold after exercise
2,748
$34.71
$95.38K
Melissa B, Epperly
29 Jun 2026
Director
Sold after exercise
15,002
$34.32
$514.87K
Mayukh Sukhatme
26 Jun 2026
President & CIO
Sold after exercise
500,000
$34.08
$17.04M
Mayukh Sukhatme
25 Jun 2026
President & CIO
Sold after exercise
500,000
$34.13
$17.07M
Eric Venker
24 Jun 2026
President & Immunovant CEO
Sold after exercise
46,234
$33.51
$1.55M
Eric Venker
24 Jun 2026
President & Immunovant CEO
Sold after exercise
153,766
$33.05
$5.08M
Eric Venker
22 May 2026
President & Immunovant CEO
Sold after exercise
200,000
$30.27
$6.05M
Eric Venker
20 Apr 2026
President & Immunovant CEO
Sold after exercise
200,000
$29.59
$5.92M
Meghan Fitzgerald
26 Mar 2026
Director
Sold after exercise
70,000
$27.45
$1.92M
Eric Venker
17 Mar 2026
President & Immunovant CEO
Sold after exercise
200,000
$28.24
$5.65M
Frank Torti
23 Feb 2026
President and Vant Chair
Sold after exercise
587,390
$27.51
$16.16M
Frank Torti
20 Feb 2026
President and Vant Chair
Sold after exercise
1,012,610
$27.15
$27.49M
Frank Torti
19 Feb 2026
President and Vant Chair
Sold after exercise
1,400,000
$27.42
$38.39M
Eric Venker
13 Feb 2026
President & Immunovant CEO
Sold after exercise
200,000
$26.49
$5.30M
Mayukh Sukhatme
9 Feb 2026
President & CIO
Sold after exercise
339,441
$26.47
$8.99M
Eric Venker
12 Jan 2026
President & Immunovant CEO
Sold after exercise
200,000
$21.92
$4.38M
Mayukh Sukhatme
31 Dec 2025
President & CIO
Sold after exercise
1,018,995
$21.71
$22.12M
Mayukh Sukhatme
29 Dec 2025
President & CIO
Sold after exercise
311,873
$21.74
$6.78M
Eric Venker
24 Dec 2025
President & Immunovant CEO
Sold after exercise
75,000
$22.53
$1.69M
Eric Venker
23 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$22.45
$4.49M
Richard Pulik
23 Dec 2025
CFO
Sold after exercise
146,731
$22.39
$3.29M
Richard Pulik
23 Dec 2025
CFO
Sold after exercise
260,000
$22.45
$5.84M
Mayukh Sukhatme
17 Dec 2025
President & CIO
Sold after exercise
26,831
$23.09
$619.53K
Vivek Ramaswamy
15 Dec 2025
10% owner
Sold after exercise
353,745
$22.05
$7.80M
Matthew Gline
15 Dec 2025
CEO
Sold after exercise
943,527
$21.68
$20.46M
Matthew Gline
15 Dec 2025
CEO
Sold after exercise
566,116
$21.68
$12.27M
Matthew Gline
15 Dec 2025
CEO
Sold after exercise
230,357
$21.68
$4.99M
Vivek Ramaswamy
12 Dec 2025
10% owner
Sold after exercise
1,975,858
$21.96
$43.39M
Vivek Ramaswamy
11 Dec 2025
10% owner
Sold after exercise
774,142
$21.64
$16.75M
Eric Venker
9 Dec 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.85
$4.17M
Eric Venker
7 Nov 2025
President & Immunovant CEO
Sold after exercise
200,000
$20.22
$4.04M
Show all 118 transactions →

What was left out

Form 4 filings counted 99
Amendments (4/A) skipped 0
Filings about a different issuer 2
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 8
Sales straight out of an exercise 46
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 33,682,213
History held since 17 Oct 2017